- Joined
- Apr 5, 2016
- Messages
- 1,659
Aspirin just cannot stop winning.
"A large-scale study finds that the long-term use of aspirin cuts the chances of developing digestive cancers almost in half. Gastrointestinal cancers include colorectal cancer, stomach (or gastric) cancer, liver cancer, pancreatic cancer, esophageal cancer, and small intestine cancers, among others."
"Long-term use of aspirin showed 24 percent to 47 percent significant reduction on major cancers in the [gastrointestinal] tract," write the authors.
"More specifically, aspirin users were 47 percent less likely to have liver and esophageal cancer, 38 percent less likely to have stomach cancer, and 34 percent less likely to have pancreatic cancer."
"The study spanned 10 years and included more than 600,000 participants. The findings were presented at the 25th United European Gastroenterology Week, held in Barcelona, Spain."
"Prof. Tsoi and his colleagues examined 618,884 participants, 206,295 of whom were aspirin users. Patients taking aspirin were aged 67.5 years, on average, and those who weren't were aged 67.6 years, on average."
Link to article below, trying to find a link to the study.
Aspirin slashes risk of gastrointestinal cancer
"A large-scale study finds that the long-term use of aspirin cuts the chances of developing digestive cancers almost in half. Gastrointestinal cancers include colorectal cancer, stomach (or gastric) cancer, liver cancer, pancreatic cancer, esophageal cancer, and small intestine cancers, among others."
"Long-term use of aspirin showed 24 percent to 47 percent significant reduction on major cancers in the [gastrointestinal] tract," write the authors.
"More specifically, aspirin users were 47 percent less likely to have liver and esophageal cancer, 38 percent less likely to have stomach cancer, and 34 percent less likely to have pancreatic cancer."
"The study spanned 10 years and included more than 600,000 participants. The findings were presented at the 25th United European Gastroenterology Week, held in Barcelona, Spain."
"Prof. Tsoi and his colleagues examined 618,884 participants, 206,295 of whom were aspirin users. Patients taking aspirin were aged 67.5 years, on average, and those who weren't were aged 67.6 years, on average."
Link to article below, trying to find a link to the study.
Aspirin slashes risk of gastrointestinal cancer